Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs

Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 1,824

Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review

Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA

Pharmaceutical industry and healthcareGlobal Public Health Policies and Epidemiology

Cited by 1,816

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics

Pharmacogenetics and Drug MetabolismNeurotransmitter Receptor Influence on Behavior

Cited by 1,788

New Methods of Drug Delivery

Langer, R. (1990) · Science

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 1,778

Role of Quinones in Toxicology

Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology

Bioactive Compounds and Antitumor AgentsCarcinogens and Genotoxicity Assessment

Cited by 1,703

Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies

Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery

Advanced Drug Delivery SystemsProtein purification and stability

Cited by 1,702

Industry sponsorship and research outcome

Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews

Pharmaceutical industry and healthcareGlobal Public Health Policies and Epidemiology

Cited by 1,697

Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results

Suñé, P., Suñé, J. M., & Montoro, J. B. (2013) · PLoS ONE

Pharmaceutical industry and healthcareMeta-analysis and systematic reviews

Cited by 1,687

Drug delivery systems: An updated review

Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation

Advanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Cited by 1,671

Polymers for Drug Delivery Systems

Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 1,608

Drug-induced hepatotoxicity

Lee, W. M. (2003) · New England Journal of Medicine

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 1,594

Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries

Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology

Pharmacovigilance and Adverse Drug ReactionsDrug-Induced Hepatotoxicity and Protection

Cited by 1,481

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 1,478

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products

Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics

Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery Systems

Cited by 1,478

The SIDER database of drugs and side effects

Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P. (2016) · Nucleic Acids Research

Pharmacovigilance and Adverse Drug ReactionsBiomedical Text Mining and Ontologies

Cited by 1,451

Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)

Mao, Q.-Q., Xu, X.-Y., Cao, S.-Y., Gan, R.-Y., Corke, H., Beta, T., & Li, H.-B. (2019) · Foods

Ginger and Zingiberaceae researchGarlic and Onion Studies

Cited by 1,418

Insoluble drug delivery strategies: review of recent advances and business prospects

Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 1,410

Ocular drug delivery

Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal

Advanced Drug Delivery SystemsOcular Infections and Treatments

Cited by 1,406

Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research

Drug Solubulity and Delivery SystemsDrug Transport and Resistance Mechanisms

Cited by 1,401

The evolution of commercial drug delivery technologies

Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 1,361

Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach

des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 1,305

Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes

Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry

Drug Solubulity and Delivery SystemsComputational Drug Discovery Methods

Cited by 1,304

Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications

D’souza, A. A., & Shegokar, R. (2016) · Expert Opinion on Drug Delivery

Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems

Cited by 1,282

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 1,280